Justin Oldham
Associate Professor & Director, Interstitial Lung Disease Research University of Michigan
Seminars
Wednesday 20th August 2025
Panel Discussion: Hear from the Clinicians – What Will Constitute First-Line Therapy for IPF in an Evolving Landscape?
3:30 pm
With new therapies on the horizon, the IPF treatment landscape is evolving. This panel brings together leading clinicians and academics to explore how emerging drugs will fit into current treatment paradigms. Experts will discuss the clinical decision-making process for first-line therapy, balancing efficacy, safety, and patient-specific factors.
Wednesday 20th August 2025
Exploring Multi Marker Modelling to Inform Prediction Modelling for Optimizing Patient Selection
11:00 am
- Exploring multi-marker modeling and the potential of combining biomarkers to improve prognostication and patient selection for ILD clinical trials
- Assessing how biomarkers can be used to predict treatment response in ILD
- Evaluating multi-modal biomarker strategies that incorporate data from clinical, genomic, proteomic, and imaging domains to improve outcome discrimination in ILD
